Soy lecithin Pharma Grade
59403-51-9
Pharmaceutical Grade
SHANGHAI
25kg/2.5kg Fiber Drum
2017-06-25
Soy lecithin Soy lecithin
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferencePSPC; PC(16:0-18:0), also known as 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine, is an assymetrical phospholipid containing saturated palmitic and stearic acid at the sn-1 and sn-2 position respectively. The phosphate group is attached to choline.
ChEBI: 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine is a phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively. It has a role as a mouse metabolite. It is functionally related to a hexadecanoic acid and an octadecanoic acid.Basic Info-
Product Name:
1-PALMITOYL-2-STEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
Other Name:1-PALMITOYL-2-STEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE;16:0-18:0 PC;16:0-18:0 PC;1-PALMITOYL-2-STEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE;1-PALMITOYL-2-STERAOYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE;[(2R)-3-hexadecanoyloxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate;Lecithin Impurity 19;(R)-3-(Palmitoyloxy)-2-(stearoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate;Nicotinamide Impurity 78
CAS No.:59403-51-9
Molecular Formula:C42H84NO8P
InChIKeys:PZNPLUBHRSSFHT-RRHRGVEJSA-N
Molecular Weight:762.09
Characteristics-
Critical Temperature & Pressure:
-20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Soy lecithin Soy lecithin
-
Payment Terms:
D/P,L/C
-
Average lead Time:
60
-
Total Annual Revenue:
Less than $1 million
The company's existing fixed assets of 10 million yuan, is an emerging private high-tech company. The company has newly built workshops that comply with GMP standards: 10,000-level and 100,000-level purification workshops, and has set up an equipment (annual output) of 10 tons of soybean phospholipid for injection. We have successively launched a series of products such as soybean lecithin for intravenous injection and soybean lecithin for high-purity fat milk. In July 1998, the company's intravenous soybean phospholipid project was recognized as the first batch of high-tech achievement transformation projects in Shanghai. In June 1999, he obtained the license of the pharmaceutical production enterprise, and in June 2001, the State Drug Administration approved the "Soybean Phospholipid Production Number for Injection". The project was also recognized as a key state-level key project by the Ministry of Science and Technology, and a 700,000 yuan innovation fund was allocated to encourage and support it. In 2000, on the basis of our company's separation and extraction process innovation, after a period of repeated trial production, the trial production of egg yolk phospholipids for injection was completed. In 2001, the process enlargement was completed, and the process equipment for mass production was successfully set up, and the PC content of its products can reach more than 95%. This is another industry-wide filling of domestic gaps.
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product